According to the World Health Organization, one in three adults suffer from hypertension – that is 1.5 billion adults worldwide. The paradox of hypertension is that most people suffering from this condition are unaware of it. And, with the current “gold standard” being cumbersome, patients and healthcare professionals alike lack access to complete and high- quality data for their diagnosis and the treatment of this disease.
For more than 15 years, our founders, Josep Solà and Mattia Bertschi together with their team at CSEM, have invested their time and energy in the development of non-occlusive blood pressure monitoring solutions. This led to a strong patent portfolio, more than 30 peer-reviewed publications, 4 clinical trials in acute and low-acute settings involving 3 university hospitals and 150 patients. In December 2017 Josep Solà was awarded the Neode Prize for this breakthrough research.
Now, we are ready to commercialize this revolutionary technology for cuffless optical Blood Pressure Monitoring (oBPM™) at the wrist.